4-((4-Fluorobenzyl)amino)-6-fluoroquinazoline
CAS: 1262888-28-7
Rif. 3D-FF89604
1mg | Fuori produzione | ||
2mg | Fuori produzione | ||
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- Spautin-1
- 6-Fluoro-N-[(4-fluorophenyl)methyl]-4-quinazolinamine
- 4-Quinazolinamine, 6-fluoro-N-[(4-fluorophenyl)methyl]-
- MBCQ deriv. C43
4-((4-Fluorobenzyl)amino)-6-fluoroquinazoline is a drug used to treat eye disorders. It has been shown to be an effective inhibitor of autophagy, which is a process where cells digest their own components during starvation or other metabolic stress. Cancer cells use this process to survive and grow. 4-((4-Fluorobenzyl)amino)-6-fluoroquinazoline can also inhibit cellular transformation (the conversion of normal cells into cancer cells). It binds to specific intracellular targets and inhibits the activity of enzymes involved in the apoptosis pathway, leading to cell death. This drug has also been shown to be effective in mouse tumor models and prevention of balloon injury in rats.